Aerie: 3Q Earnings Snapshot

November 6, 2018

NORTH CAROLINA, N.C. (AP) _ Aerie Pharmaceuticals Inc. (AERI) on Tuesday reported a loss of $85.4 million in its third quarter.

The North Carolina, North Carolina-based company said it had a loss of $1.96 per share. Losses, adjusted for non-recurring costs, were $1.73 per share.

The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of $1.33 per share.

The drugmaker posted revenue of $7.3 million in the period, exceeding Street forecasts. Three analysts surveyed by Zacks expected $5.6 million.

Aerie expects full-year revenue in the range of $20 million to $30 million.

Aerie shares have fallen almost 9 percent since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $54.55, a decrease of 16 percent in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AERI at https://www.zacks.com/ap/AERI

Update hourly